Gain Therapeutics (GANX) Current Deferred Revenue (2020 - 2025)
Gain Therapeutics (GANX) posted Current Deferred Revenue of $11,293 for Q3 2025, down 98.4% from $708,027 a year earlier and down 50.2% from the prior quarter.
Powered by 
Analysis
Gain Therapeutics (GANX) Current Deferred Revenue (2020 - 2025) Analysis & Trends
At the end of FY2024, Gain Therapeutics' Current Deferred Revenue came in at $252,211, down 77.5% from FY2023.
- Annual Current Deferred Revenue shows a four-year compound annual growth rate of 1.3% (FY2020 to FY2024).
- In prior years, Gain Therapeutics' Current Deferred Revenue was $1.12 million in FY2023, $55,180 in FY2022 (-79.3%), $266,504 in FY2021 (+11.3%) and $239,483 in FY2020.
- The Q3 2025 figure stands as the lowest quarterly Current Deferred Revenue in data going back to Q4 2020.
- On a year-over-year basis, Current Deferred Revenue has declined in each of the last six quarters, with an average decline of 71.7% over the last six quarters.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q1 2022, with growth of 13.2%; the weakest was Q3 2025, with a decline of 98.4%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $22,685 (Q2 2025), $217,841 (Q1 2025) and $252,211 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Gain Therapeutics | 51.03 Mn | -8.26 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 11,293.00 |
| Jun 30, 2025 | 22,685.00 |
| Mar 31, 2025 | 217,841.00 |
| Dec 31, 2024 | 252,211.00 |
| Sep 30, 2024 | 708,027.00 |
| Jun 30, 2024 | 710,001.00 |
| Mar 31, 2024 | 914,759.00 |
| Dec 31, 2023 | 1.12 Mn |
| Sep 30, 2023 | 1.35 Mn |
| Jun 30, 2023 | 1.07 Mn |
| Dec 31, 2022 | 55,180.00 |
| Sep 30, 2022 | 55,180.00 |
| Jun 30, 2022 | 80,198.00 |
| Mar 31, 2022 | 202,034.00 |
| Dec 31, 2021 | 266,504.00 |
| Sep 30, 2021 | 327,690.00 |
| Jun 30, 2021 | 370,518.00 |
| Mar 31, 2021 | 178,418.00 |
| Dec 31, 2020 | 239,483.00 |
API Access
Gain Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=GANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();